Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
The Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. Invesco Dynamic Pharmaceuticals ETF (PJP) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. XLVI is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.57% for PJP. XLVI is up 0.28% year-to-date (YTD) with +$2M in YTD flows. PJP performs better with 0.96% YTD performance, and +$89M in YTD flows. Run a side-by-side ETF comparison of XLVI and PJP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLVI PJP | -1.07%-3.66% | +1.89%+0.35% | +0.28%+0.96% | n/a+25.49% | n/a+46.89% | n/a+39.70% |
| Flows | XLVI PJP | +$788K+$6M | +$3M+$93M | +$2M+$89M | -+$91M | -+$6M | --$49M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLVI PJP | +10.15%+14.70% | n/a+18.60% | n/a+15.30% | n/a+15.87% |
| Max drawdown | XLVI PJP | -3.26%-5.17% | n/a-13.71% | n/a-16.11% | n/a-17.41% |
| Max drawdown duration | XLVI PJP | 10d31d | n/a130d | n/a275d | n/a788d |
XLVI | PJP | |
Last sale 3/11/2026 at 7:59 PM | $25.92 | $103.91 |
| Previous close 03/11/2026 | $25.98 | $105.46 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XLVI | PJP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XLVI | PJP | |
|---|---|---|
| Last price | $25.92 | $103.91 |
| 1D performance | -0.23% | -1.47% |
| AuM | $13.24 M | $406.31 M |
| E/R | 0.35% | 0.57% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
